These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10922135)

  • 1. Novel pathways in the pathogenesis of respiratory syncytial virus disease.
    van Schaik SM; Welliver RC; Kimpen JL
    Pediatr Pulmonol; 2000 Aug; 30(2):131-8. PubMed ID: 10922135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis.
    Dakhama A; Vitalis TZ; Hegele RG
    Eur Respir J; 1997 Jan; 10(1):20-6. PubMed ID: 9032486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of leukotrienes and eosinophil cationic protein in acute respiratory syncytial virus bronchiolitis.
    Dimova-Yaneva DN; Helms PJ
    Folia Med (Plovdiv); 2003; 45(3):5-11. PubMed ID: 15366660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus infections: old challenges and new opportunities.
    Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-induced airway dysfunction: pathogenesis and biomechanisms.
    Dakhama A; Lee YM; Gelfand EW
    Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S159-69, discussion S166-7. PubMed ID: 16378041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy.
    Pala P; Bjarnason R; Sigurbergsson F; Metcalfe C; Sigurs N; Openshaw PJ
    Eur Respir J; 2002 Aug; 20(2):376-82. PubMed ID: 12212970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma.
    Martinez FD
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S76-82. PubMed ID: 12671456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses and disease enhancement during respiratory syncytial virus infection.
    Openshaw PJ; Tregoning JS
    Clin Microbiol Rev; 2005 Jul; 18(3):541-55. PubMed ID: 16020689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus and other respiratory viruses.
    Welliver RC
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S6-10; discussion S10-2. PubMed ID: 12671447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus and reactive airway disease.
    Lotz MT; Moore ML; Peebles RS
    Curr Top Microbiol Immunol; 2013; 372():105-18. PubMed ID: 24362686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection.
    de Waal L; Koopman LP; van Benten IJ; Brandenburg AH; Mulder PG; de Swart RL; Fokkens WJ; Neijens HJ; Osterhaus AD
    J Med Virol; 2003 Jun; 70(2):309-18. PubMed ID: 12696123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing.
    Rossi GA; Colin AA
    Eur Respir J; 2015 Mar; 45(3):774-89. PubMed ID: 25359340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implications.
    Barreira ER; Precioso AR; Bousso A
    Pediatr Pulmonol; 2011 May; 46(5):415-20. PubMed ID: 21194166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis.
    Korppi M; Kotaniemi-Syrjänen A; Waris M; Vainionpää R; Reijonen TM
    Pediatr Infect Dis J; 2004 Nov; 23(11):995-9. PubMed ID: 15545853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis.
    Bont L; Aalderen WM; Kimpen JL
    Paediatr Respir Rev; 2000 Sep; 1(3):221-7. PubMed ID: 12531083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
    Bont L; Kimpen JL
    Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.